Communiqués

14/05 BIOREM Reports First Quarter Financial Results and Record $77 Million Order Backlog, Revenue Increase of 44% AQ
23/04 BioRem : 2025 Q4 Financial Statements PU
23/04 BioRem : 2025 Q4 MD&A PU
20/04 Biorem Reports $65.3 Million Order Backlog AQ
20/04 Biorem Reports Record Revenues and Earnings before tax for 2025 AQ
17/11 Biorem Reports Record Order Backlog, - $11.3 Million of Revenues in the Quarter and Quarterly EPS of $0.07 AQ
02/09/25 BioRem : 2025 Q2 - Condensed consolidated interim financial statements of Biorem Inc. PU
02/09/25 BioRem : 2025 Q2 MD&A PU
25/08/25 Biorem Reports Second Quarter Results AQ
11/06/25 BIOREM Announces Approval of Normal Course Issuer Bid AQ
28/05/25 BioRem : 2025-Q1-MD&A PU
28/05/25 BIOREM Reports First Quarter Financial Results and Record $68 Million Order Backlog AQ
16/04/25 Biorem Reports Record Revenues and Earnings before tax for 2024 and Again Reports Record Order Backlog AQ
11/02/25 BIOREM Announces Orders Totalling $8 Million and Order Backlog of $60.5 Million AQ
09/12/24 BIOREM Announces New Orders Totalling $13 Million and Order Backlog of $58 Million AQ
14/11/24 BioRem : 2024-Q3 Condensed Consolidated Interim Financial Statements PU
14/11/24 BioRem : 2024 Q3 MD&A PU
06/11/24 Biorem Reports Record Quarterly Revenues and Earnings, - $14.9 Million of Revenues in the Quarter and Quarterly EPS of $0.14 AQ
20/09/24 BioRem : 2024 Q2 MD&A PU
26/08/24 Biorem Reports Second Quarter Results with 77% Increase in Year over Year Revenue and Record Order Backlog AQ
05/06/24 Biorem Announces Stock Option Grant AQ
28/05/24 BIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order Backlog AQ
28/05/24 BIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order Backlog PR
11/04/24 Biorem Reports 2023 Financial Results including $0.14 earnings per share AQ
29/11/23 Biorem Reports Third Quarter Results, Record Order Backlog and Quarterly EPS of $0.03 AQ
Aucun résultat pour cette recherche